Canaan IX L.P. (CIK 0001538676)

Latest company ownership

Shares held
2,494,381
Last filed at
Mar 28, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 29, 2016 Dec 1, 2016 CytomX Therapeutics, Inc. Director Sell 22.5 -422,086 -11.51% ✗ $247K
Nov 23, 2016 Nov 28, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -38,459 -1.04% ✗ $444.4K
Nov 22, 2016 Nov 22, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -42,550 -1.14% ✗ $498.1K
Nov 17, 2016 Nov 21, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -45,324 -1.20% ✗ $526.1K
Nov 15, 2016 Nov 16, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -51,581 -1.34% ✗ $593.4K
Nov 10, 2016 Nov 14, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -86,270 -2.19% ✗ $962.9K
Nov 9, 2016 Nov 10, 2016 CytomX Therapeutics, Inc. Director Sell 40.0 -13,730 -0.35% ✗ $151.5K
Jun 8, 2016 Jun 10, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -48,427 -1.13% ✗ $487.5K
Jun 6, 2016 Jun 8, 2016 CytomX Therapeutics, Inc. Director Sell 17.5 -111,498 -2.53% ✗ $1.1M
Jun 2, 2016 Jun 6, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -59,621 -1.34% ✗ $644K
Jun 1, 2016 Jun 2, 2016 CytomX Therapeutics, Inc. Director Sell 32.5 -22,463 -0.50% ✗ $241.5K
May 27, 2016 Jun 1, 2016 CytomX Therapeutics, Inc. Director Sell 30.0 -25,082 -0.56% ✗ $265.9K
May 25, 2016 May 27, 2016 CytomX Therapeutics, Inc. Director Sell 20.0 -51,343 -1.13% ✗ $530.8K
May 23, 2016 May 25, 2016 CytomX Therapeutics, Inc. Director Sell 40.0 -13,253 -0.29% ✗ $133.7K
May 19, 2016 May 23, 2016 CytomX Therapeutics, Inc. Director Sell 47.5 -8,687 -0.19% ✗ $87.8K